|
 |
Faculty |
 |
Statement of Need |
 |
Activity Goal |
 |
Learning Objectives |
 |
Financial Support |
 |
Target Audience |
 |
Credit Information |
Connecting the Dots in Fibromyalgia: Linking the Pathophysiology to Improved Diagnostic, Treatment, and Management Decisions (Part 2 of 5)
neuroscienceCME Multimedia Snack
Premiere Date: Saturday, July 30, 2011This activity offers CE credit for:
- Physicians (CME)
- Pharmacists (ACPE)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Monday, July 30, 2012
Note: Credit Is No Longer Available
 | Lesley M. Arnold, MD (Moderator) Professor of Psychiatry and Behavioral Neuroscience Director, Women's Health Research Program University of Cincinnati College of Medicine Cincinnati, OH |
 | Shay Stanford, MD Adjunct Assistant Professor of Psychiatry and Family Medicine Assistant Director, Women's Health Research Program University of Cincinnati College of Medicine Cincinnati, OH |
 | David A. Williams, PhD Professor of Anesthesiology and Medicine (Rheumatology) Professor of Psychiatry and Psychology Associate Director, Chronic Pain and Fatigue Research Center University of Michigan Ann Arbor, MI |
Fibromyalgia affects 2% to 12% of the adult population in the U.S.(1) and is characterized by widespread muscular and soft tissue pain of varying intensity over time. Many patients have additional symptoms including fatigue, headaches, irritable bowel syndrome, cognitive problems or memory lapses, sleep disturbances, anxiety, and depression. Most patients first present to their primary care physicians with the set of complex, overlapping symptoms.(2)
In a recent survey of neuroscienceCME Clinical Compass™ subscribers, 62.8% of physician respondents lacked confidence in their ability to diagnose and manage fibromyalgia. Education that addresses these diverse symptom domains, as well as comorbid medical and psychiatric conditions, will shift usual clinician thinking about pain and equip physicians and the treatment team with the tools needed to better manage fibromyalgia. This neuroscienceCME Snack will provide guidance on appropriate pharmacotherapy options based on the biological basis of the disorder, as well methods to develop and participate in an interdisciplinary care team that empowers the patient, focuses on treating individual symptoms, and coordinates supportive care.
- Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
- Russell IJ, Raphael KG. Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability. CNS Spectr 2008;13:6-11.
To change clinical thinking to account for the pathophysiology, complexities, and comorbidities of the patient with fibromyalgia, enabling participants to improve self-efficacy in fibromyalgia management and apply multimodal and multidisciplinary approaches to treatment that addresses patient expectations and individualizes treatment needs.
At the end of this CE activity, participants should be able to:
- Apply multimodal and multidisciplinary approaches to fibromyalgia treatment—approaches that address patient expectations and individualize treatment needs including patient education, pharmacotherapy, nonpharmacologic approaches, exercise, cognitive therapy, etc.
Supported by an educational grant from Pfizer Inc.
Primary care physicians, physician assistants, nurse practitioners, pharmacists, and other health care professionals interested in fibromyalgia.
CME Credit (Physicians):
Indiana University School of Medicine, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Indiana University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hours (0.05 CEUs)
Universal Activity Number: 0376-0000-11-014-H01-P (recorded programs)
Activity Type: knowledge-based
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of Indiana University School of Medicine and CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. Indiana School of Medicine and CME Outfitters, LLC, have evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Arnold has disclosed that she receives grants/research support from Allergan, Inc., Boehringer Ingelheim Pharamceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Pfizer Inc., and Wyeth Pharmaceuticals. She serves as a consultant to Allergan, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharamceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Pfizer Inc., Sanofi-aventis, Takeda Pharmaceuticals North America, Inc., Theravance, Inc., UCB Pharma, and Wyeth Pharmaceuticals.
Dr. Stanford has disclosed that she receives research support from Boehringer Ingelheim Pharmaceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, and Pfizer, Inc.
Dr. Williams has disclosed that he receives a consulting fee from Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Jazz Pharmaceuticals, and Pfizer Inc. He receives honoraria from Eli Lilly and Company and Forest Laboratories, Inc.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Joy B. Leffler, MLA, NASW (planning committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Indiana University School of Medicine, CME Outfitters, LLC, the faculty, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
SN-024-073011-02
